Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

BUY
$31.15 - $33.39 $1.39 Million - $1.49 Million
44,515 New
44,515 $1.48 Million
Q2 2022

Aug 10, 2022

BUY
$23.75 - $31.69 $209,783 - $279,917
8,833 New
8,833 $264,000
Q2 2021

Aug 06, 2021

SELL
$18.01 - $28.32 $153,066 - $240,691
-8,499 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$19.76 - $29.89 $167,940 - $254,035
8,499 New
8,499 $224,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.